Compile Data Set for Download or QSAR
maximum 50k data
Found 218 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase Nek7'
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523007(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522989(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522991(1-(4-(4-amino-7-(2- hydroxy-2- methylpropyl)-7H- p...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522987(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522991(1-(4-(4-amino-7-(2- hydroxy-2- methylpropyl)-7H- p...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523003(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523005(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522958(1-(4-(4-amino-7- (oxetan-3-yl)-7H- pyrrolo[2,3- d]...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523005(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522987(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522958(1-(4-(4-amino-7- (oxetan-3-yl)-7H- pyrrolo[2,3- d]...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523015(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523007(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523015(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523003(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522989(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522990(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522988(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522959(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523022(1-(4-(4-amino-7-(1- methylpyrrolidin-3-yl)- 7H-pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523019(1-(4-(4-amino-7- cyclobutyl-7H- pyrrolo[2,3- d]pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523006(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523004(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523002(1-(4-(4-amino-7-(1- methylpiperidin-4-yl)- 7H-pyrr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522999(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522995(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522990(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522988(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522959(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523022(1-(4-(4-amino-7-(1- methylpyrrolidin-3-yl)- 7H-pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523019(1-(4-(4-amino-7- cyclobutyl-7H- pyrrolo[2,3- d]pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523006(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523004(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523002(1-(4-(4-amino-7-(1- methylpiperidin-4-yl)- 7H-pyrr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522999(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522995(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523008(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522983(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523012(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523014(1-(5-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523012(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523008(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523000(1-(4-(4-amino-7- (pyridin-3-yl)-7H- pyrrolo[2,3- d...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523014(1-(5-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522983(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523023(1-(4-(4-amino-7- cyclobutyl-7H- pyrrolo[2,3- d]pyr...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522972(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522972(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523001(1-(4-(4-amino-7- (pyridin-4-yl)-7H- pyrrolo[2,3- d...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and κ caseins, obtained from Sigma Aldri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523001(1-(4-(4-amino-7- (pyridin-4-yl)-7H- pyrrolo[2,3- d...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 218 total ) | Next | Last >>
Jump to: